Drugs that induce a distinctive, subjective altered state of consciousness—broadly referred to as “Psychedelics”— stand to revolutionize the treatment of mental disorders. At present only one such drug, Ketamine, is FDA-approved for human use and, therefore, can be prescribed (off-label) to treat mental illness. However, many more psychedelics are under development including MDMA and Psilocybin, […]